Stockscreener 앱 받기
9.33
10.63%
-1.11
전일 마감가:
$10.44
열려 있는:
$9.26
하루 거래량:
5,675
Relative Volume:
0.32
시가총액:
$99.66M
수익:
$72.33M
순이익/손실:
$-8.38M
주가수익비율:
-11.84
EPS:
-0.7881
순현금흐름:
$-4.95M
1주 성능:
+0.86%
1개월 성능:
-0.74%
6개월 성능:
-63.88%
1년 성능:
+9.51%
1일 변동 폭
$9.26
$9.45
1주일 범위
$9.108
$10.90
52주 변동 폭
$6.79
$41.72
Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile
Compare BNR vs TMO, DHR, NTRA, A, IQV
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BNR
Burning Rock Biotech Ltd Adr
|
9.45 | 97.55M | 72.33M | -8.38M | -4.95M | -0.7881 |
TMO
Thermo Fisher Scientific Inc
|
633.52 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
217.72 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
338.79 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
158.16 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
263.88 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
Burning Rock Biotech Ltd Adr Stock (BNR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2020-07-07 | 개시 | Cowen | Outperform |
Burning Rock Biotech Ltd Adr 주식(BNR)의 최신 뉴스
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 3.7%What's Next? - MarketBeat
Price to sales forward of Burning Rock Biotech Ltd. Sponsored ADR – FWB:6BU0 - TradingView
Burning Rock Biotech Limited Sponsored ADR $BNR Shares Sold by Crcm LP - MarketBeat
Price to sales forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Enterprise value to EBITDA forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Enterprise value to revenue forward of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Burning Rock CEO purchases $618,218 in company shares - Investing.com
Burning Rock Biotech Ltd. Sponsored ADR Financial Disclosures & Filings - TradingView
Enterprise value to EBIT forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Enterprise value to revenue forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Price to book forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Price to earnings forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0 - TradingView
Burning Rock Biotech Ltd. Sponsored ADR Actuals & Estimates (NASDAQ:BNR) - TradingView
Burning Rock Biotech Ltd. Sponsored ADR Actuals & Estimates (LS:A40AE6) - TradingView
Why These High-Flying Stocks Came Back To Earth - Sahm
Which countries contribute most to Burning Rock (BNR) revenue? (Overhead Buying) 2026-05-01Momentum ETF - newsline.com
ETFs Investing in Burning Rock Biotech Ltd. Sponsored ADR Stocks - TradingView
Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR) Short Interest Update - MarketBeat
Burning Rock Biotech (NASDAQ: BNR) 2025 loss narrows amid China and HFCAA risks - Stock Titan
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 1.3%What's Next? - MarketBeat
Cancer screening company Faces Tough IPO Test As Market Cools - Benzinga
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer By Investing.com - Investing.com South Africa
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer - Investing.com
Burning Rock Biotech (NASDAQ:BNR) Director Purchases $5,466,143.20 in Stock - MarketBeat
Burning Rock CEO purchases $546,604 in company shares - Investing.com
Burning Rock CEO purchases $546,604 in company shares By Investing.com - Investing.com India
Burning Rock Biotech (BNR) Expected to Announce Earnings on Tuesday - MarketBeat
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 9.8%Here's What Happened - MarketBeat
(BNR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Burning Rock Biotech (BNR) Stock Price, News & Analysis $BNR - MarketBeat
Burning Rock Biotech (NASDAQ:BNR) Trading Down 9.7%Here's What Happened - MarketBeat
Intel and AMD among market cap stock movers on Friday By Investing.com - Investing.com Australia
Intel, Iris Energy among market cap stock movers on Friday - Investing.com
Alibaba and Facebook among market cap stock movers on Thursday - Investing.com
This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs - Yahoo Finance
KindlyMD (NAKA) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
BNR: Revenue up 9.6% and net loss narrowed, with strong pharma R&D and cost controls - TradingView
BNR: Net loss narrowed 89% year-over-year as pharma R&D revenue surged and margins improved - TradingView
BNR: 2024 revenue fell 4% to RMB515.8M, net loss narrowed 47%, in-hospital segment now leads - TradingView
BNR: Commercial breakeven reached in FY2024, with strong margins and leadership in early cancer detection - TradingView
BNR: Net loss narrowed and gross margin improved as in-hospital and pharma R&D revenues grew - TradingView
BNR: In-hospital revenue rose 11.2% and net loss narrowed as the business shifted away from central-lab testing - TradingView
Japan Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
Burning Rock Biotech Ltd Share Price ADR Each Representing 10 Ord A Shares SPON - Hargreaves Lansdown
symbol__ Stock Quote Price and Forecast - CNN
Recent Insider BuyingStock ScreenerSnapshot - Finviz
These stocks are moving in today's after hours session - ChartMill
What is the current Price Target and Forecast for Burning Rock Biotech (BNR) - Zacks Investment Research
Which stocks are gapping on Monday? - ChartMill
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
Burning Rock Biotech Ltd Adr (BNR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Burning Rock Biotech Ltd Adr 주식 (BNR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Han Yusheng | Director |
Jun 12 '26 |
Buy |
9.25 |
210,000 |
1,942,143 |
17,907,436 |
| Han Yusheng | Director |
Jun 16 '26 |
Buy |
9.00 |
111,110 |
999,957 |
18,018,546 |
| Han Yusheng | Director |
Jun 22 '26 |
Buy |
7.45 |
104,650 |
779,674 |
18,123,196 |
| Han Yusheng | Director |
Jun 11 '26 |
Buy |
8.74 |
24,760 |
216,388 |
17,697,436 |
| Han Yusheng | Director |
Jun 26 '26 |
Buy |
8.00 |
24,900 |
199,090 |
18,404,086 |
| Han Yusheng | Director |
Jun 23 '26 |
Buy |
7.50 |
5,990 |
44,920 |
18,129,186 |
| Han Yusheng | Director |
Mar 31 '26 |
Buy |
17.36 |
314,870 |
5,466,143 |
17,672,676 |
0.91%
0.52%
자본화:
|
볼륨(24시간):